Nexus BioPharma is a biotechnology company focused on the development and commercialization of a pharmaceutical preparation to treat obesity and the symptoms of type 2 diabetes. Its approach targets an established metabolic pathway to stimulate weight loss and optimize blood chemistry, including lower blood glucose, cholesterol, insulin, insulin resistance, and triglycerides.